These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 28840453)

  • 21. Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.
    Zamarin D; Jazaeri AA
    Gynecol Oncol; 2016 Apr; 141(1):86-94. PubMed ID: 27016233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
    Wong RL; Yu EY
    Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance for immunoregulation for long-term cancer control.
    Fusi A; Dalgleish A
    Future Oncol; 2017 Aug; 13(18):1619-1632. PubMed ID: 28776411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic-Based Therapy of Gynecologic Malignancies.
    Markman M
    Acta Med Acad; 2019 Apr; 48(1):84-89. PubMed ID: 31264436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-based immunotherapy in gynecologic malignancies.
    Schaar B; Krishnan V; Tallapragada S; Dorigo O
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):23-30. PubMed ID: 29227304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Masterful Antibodies: Checkpoint Blockade.
    Lonberg N; Korman AJ
    Cancer Immunol Res; 2017 Apr; 5(4):275-281. PubMed ID: 28373215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research.
    Gadducci A; Guerrieri ME
    Anticancer Res; 2017 Nov; 37(11):5955-5965. PubMed ID: 29061774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-programmed Death-1 Immunotherapy for Endometrial Cancer with Microsatellite Instability-High Tumors.
    Sobecki-Rausch J; Barroilhet L
    Curr Treat Options Oncol; 2019 Nov; 20(11):83. PubMed ID: 31754884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers.
    Liu YL; Zamarin D
    Curr Oncol Rep; 2018 Nov; 20(12):94. PubMed ID: 30421009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advancing Drug Development in Gynecologic Malignancies.
    Beaver JA; Coleman RL; Arend RC; Armstrong DK; Bala S; Mills GB; Sood AK; Herzog TJ
    Clin Cancer Res; 2019 Aug; 25(16):4874-4880. PubMed ID: 31126961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to date].
    Hamanishi J; Mandai M; Konishi I
    Nihon Rinsho; 2017 Feb; 75(2):234-244. PubMed ID: 30562858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing immunotherapy for gynecologic cancers.
    Rubinstein MM; Makker V
    Curr Opin Obstet Gynecol; 2020 Feb; 32(1):1-8. PubMed ID: 31833942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer immunotherapy].
    Kjeldsen JW; Donia M; Svane IM
    Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy for gynecologic cancers.
    Liao JB
    Gynecol Oncol; 2016 Jul; 142(1):3-5. PubMed ID: 27242186
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials.
    Huynh J; Patel K; Gong J; Cho M; Malla M; Parikh A; Klempner S
    Curr Treat Options Oncol; 2021 Sep; 22(11):100. PubMed ID: 34524553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
    Nixon AB; Schalper KA; Jacobs I; Potluri S; Wang IM; Fleener C
    J Immunother Cancer; 2019 Nov; 7(1):325. PubMed ID: 31775882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian Cancer Immunotherapy: Turning up the Heat.
    Ghisoni E; Imbimbo M; Zimmermann S; Valabrega G
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.